enVVeno Medical (NVNO) Operating Expenses (2017 - 2026)

enVVeno Medical has reported Operating Expenses for 10 years, with the latest figure at $4.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 18.01% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $20.0 million (down 14.05% YoY), and the FY2025 full-year result was $20.9 million, down 12.28% from the prior year.
• Operating Expenses for Q1 2026 stood at $4.1 million, up from $4.0 million in the prior quarter.
• The five-year high for Operating Expenses was $7.0 million in Q2 2025, with the low at $4.0 million in Q4 2025.
• Average Operating Expenses over 5 years is $5.8 million, with a median of $6.2 million recorded in 2022.
• Year-over-year, Operating Expenses soared 192.79% in 2022 and tumbled 40.1% in 2025.
• Tracing NVNO's Operating Expenses over 5 years: stood at $6.5 million in 2022, then dropped by 2.82% to $6.3 million in 2023, then gained by 6.71% to $6.7 million in 2024, then plunged by 40.1% to $4.0 million in 2025, then advanced by 1.22% to $4.1 million in 2026.
• The last three Operating Expenses figures came in at $4.1 million (Q1 2026), $4.0 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.

Peer Comparison